Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 18(10): e0292156, 2023.
Article in English | MEDLINE | ID: mdl-37796941

ABSTRACT

Epitope-based peptide vaccine can elicit T-cell immunity against SARS-CoV-2 to clear the infection. However, finding the best epitope from the whole antigen is challenging. A peptide screening using immunoinformatics usually starts from MHC-binding peptide, immunogenicity, cross-reactivity with the human proteome, to toxicity analysis. This pipeline classified the peptides into three categories, i.e., strong-, weak-, and non-binder, without incorporating the structural aspect. For this reason, the molecular detail that discriminates the binders from non-binder is interesting to be investigated. In this study, five CTL epitopes against HLA-A*02:01 were identified from the coarse-grained molecular dynamics-guided immunoinformatics screening. The strong binder showed distinctive activities from the non-binder in terms of structural and energetic properties. Furthermore, the second residue from the nonameric peptide was most important in the interaction with HLA-A*02:01. By understanding the nature of MHC-peptide interaction, we hoped to improve the chance of finding the best epitope for a peptide vaccine candidate.


Subject(s)
Antineoplastic Agents , COVID-19 , Humans , COVID-19 Vaccines , Epitopes, T-Lymphocyte , SARS-CoV-2 , COVID-19/prevention & control , Molecular Dynamics Simulation , Molecular Docking Simulation , Peptides , Vaccines, Subunit , HLA-A Antigens , Epitopes, B-Lymphocyte
SELECTION OF CITATIONS
SEARCH DETAIL
...